Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Type 2 Diabetic Retinopathy”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 14 of 0 results

Not applicableActive Not RecruitingNCT07602348
What this trial is testing

Assessment of Retinal-Angio Findings In Patients With Diabetes Type II Treated With Novel Antidiabetic Therapies

Who this might be right for
Diabetic RetinopathyGLP-1SGLT 2 Inhibitors+3 more
University of Athens 40
Not applicableStudy completedNCT01145599
What this trial is testing

Identifying Progression of Retinal Disease in Eyes With NPDR in Diabetes Type 2 Using Non-invasive Procedures

Who this might be right for
Type 2 DiabetesNon Proliferative Diabetic Retinopathy
European Vision Institute Clinical Research Network 374
Not applicableUnknownNCT00846716
What this trial is testing

Shiga Progression of Diabetes, Nephropathy and Retinopathy

Who this might be right for
Type 2 Diabetes Mellitus
Shiga University 400
Not applicableStudy completedNCT00839150
What this trial is testing

Retinal Function in Diabetic Patients Without Retinopathy

Who this might be right for
Diabetes Mellitus, Type 1Diabetes Mellitus, Type 2
Assistance Publique - Hôpitaux de Paris 56
Not applicableUnknownNCT02409511
What this trial is testing

Microalbuminuria as a Cardiovascular Risk Factor (PRECISED Substudy)

Who this might be right for
MicroalbuminuriaEndothelial DysfunctionDiabetic Nephropathy+1 more
Hospital Universitari Vall d'Hebron Research Institute 75
Not applicableEnded earlyNCT04699864
What this trial is testing

Evaluation of NeoRetina Artificial Intelligence Algorithm for the Screening of Diabetic Retinopathy at the CHUM

Who this might be right for
Diabetic RetinopathyDiabetic Macular EdemaDiabetic Maculopathy
Centre hospitalier de l'Université de Montréal (CHUM) 24
Not applicableUnknownNCT04496817
What this trial is testing

Enriched Eggs for Retina Health in Type 2 Diabetes

Who this might be right for
Diabetic RetinopathyType 2 Diabetes
University of Manitoba 60
Not applicableStudy completedNCT02662010
What this trial is testing

The Relationship Between Advanced Glycation Endproducts and Diabetes

Who this might be right for
Diabetic RetinopathyType 2 Diabetes Mellitus
University of Colorado, Denver 157
Not applicableStudy completedNCT01440660
What this trial is testing

Phenotypes of Nonproliferative Diabetic Retinopathy in DM 2 Patients Identified by OCT, CFP, RLA and mfERG (DIAMARKER)

Who this might be right for
Type-2 DiabetesDiabetic Retinopathy
Association for Innovation and Biomedical Research on Light and Image 20
Not applicableStudy completedNCT02077127
What this trial is testing

Monocyte Chemoattractant Protein-1 2518A/G Polymorphism

Who this might be right for
Diabetic Retinopathy
Harbin Medical University 1,043
Not applicableUnknownNCT02671864
What this trial is testing

Incretin-mimetic Hypoglycemic Drugs and Severe Retinopathy

Who this might be right for
Type 2 Diabetes
Assistance Publique - Hôpitaux de Paris 7,200
Not applicableStudy completedNCT02232503
What this trial is testing

Prevalence of DIAbetic RETinopathy and Impact of Genetic Factors in the Development of Diabetic Retinopathy of Patients With Type 1 and 2 Diabetes Mellitus in SlovaKia

Who this might be right for
Diabetic RetinopathyDiabetic Macular EdemaDiabetes Mellitus
Novartis Slovakia, s.r.o. 4,011
Not applicableNot Yet RecruitingNCT07833228
What this trial is testing

Randomized Double-Blind Trial of Chrocare CDSS for Integrated Management of Type 2 Diabetes

Who this might be right for
Type 2 Diabetes (T2DM)Diabetic NephropathiesDiabetic Retinopathy (DR)
Shanghai Jiao Tong University School of Medicine 1,200
Post-approval studies (Phase 4)Looking for participantsNCT06662994
What this trial is testing

High Dose Aflibercept in Diabetic Macular Edema in Patients With Previous Vitrectomy

Who this might be right for
Diabetic Macular Edema (DME)
Retina Consultants of Orange County 15